These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 702282)

  • 21. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Revisiting techniques to evaluate drug permeation through skin.
    Rapalli VK; Mahmood A; Waghule T; Gorantla S; Kumar Dubey S; Alexander A; Singhvi G
    Expert Opin Drug Deliv; 2021 Dec; 18(12):1829-1842. PubMed ID: 34826250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
    Ottaviani G; Martel S; Carrupt PA
    J Med Chem; 2007 Feb; 50(4):742-8. PubMed ID: 17300161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced in vitro skin permeation of cationic drugs.
    Green PG; Hadgraft J; Ridout G
    Pharm Res; 1989 Jul; 6(7):628-32. PubMed ID: 2798314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
    Usansky HH; Sinko PJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of penetrant and vehicle mixture properties on transdermal permeability using a mixed effect pharmacokinetic model of ex vivo porcine skin.
    Chittenden JT; Riviere JE
    Biopharm Drug Dispos; 2016 Oct; 37(7):387-396. PubMed ID: 27246159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biorelevant In Vitro Skin Permeation Testing and In Vivo Pharmacokinetic Characterization of Lidocaine from a Nonaqueous Drug-in-Matrix Topical System.
    Greuber E; Vought K; Patel K; Suzuki H; Usuda K; Shiramizu A; Koplowitz LP; Koplowitz B; Maibach HI; Lissin D
    AAPS PharmSciTech; 2021 Aug; 22(6):215. PubMed ID: 34386908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards a correlation between drug properties and in vitro transdermal flux variability.
    Frum Y; Khan GM; Sefcik J; Rouse J; Eccleston GM; Meidan VM
    Int J Pharm; 2007 May; 336(1):140-7. PubMed ID: 17182201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rate-controlled drug delivery.
    Goldman P
    N Engl J Med; 1982 Jul; 307(5):286-90. PubMed ID: 7045668
    [No Abstract]   [Full Text] [Related]  

  • 30. An evaluation of the potential of linear and nonlinear skin permeation models for the prediction of experimentally measured percutaneous drug absorption.
    Brown MB; Lau CH; Lim ST; Sun Y; Davey N; Moss GP; Yoo SH; De Muynck C
    J Pharm Pharmacol; 2012 Apr; 64(4):566-77. PubMed ID: 22420662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling drug flux through microporated skin.
    Rzhevskiy AS; Guy RH; Anissimov YG
    J Control Release; 2016 Nov; 241():194-199. PubMed ID: 27686580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SAMPA: A free software tool for skin and membrane permeation data analysis.
    Bezrouk A; Fiala Z; Kotingová L; Krulichová IS; Kopečná M; Vávrová K
    Toxicol In Vitro; 2017 Oct; 44():361-371. PubMed ID: 28746894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of permeation enhancers on transdermal delivery of fluoxetine: in vitro and in vivo evaluation.
    Jung E; Kang YP; Yoon IS; Kim JS; Kwon SW; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2013 Nov; 456(2):362-9. PubMed ID: 24012861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of human percutaneous absorption from in vitro and in vivo animal experiments.
    Yoshimatsu H; Ishii K; Konno Y; Satsukawa M; Yamashita S
    Int J Pharm; 2017 Dec; 534(1-2):348-355. PubMed ID: 29111099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methods for in vitro percutaneous absorption studies. VII: Use of excised human skin.
    Bronaugh RL; Stewart RF; Simon M
    J Pharm Sci; 1986 Nov; 75(11):1094-7. PubMed ID: 3820104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interfacial kinetics effects on transdermal drug delivery: a computer modeling.
    Xing MM; Pan N; Zhong W; Hui X; Maibach HI
    Skin Res Technol; 2008 May; 14(2):165-72. PubMed ID: 18412558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier.
    Gratieri T; Kalia YN
    Adv Drug Deliv Rev; 2013 Feb; 65(2):315-29. PubMed ID: 22626977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic and empirical modeling of skin permeation of drugs.
    Yamashita F; Hashida M
    Adv Drug Deliv Rev; 2003 Sep; 55(9):1185-99. PubMed ID: 12954198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skin permeability: dermatologic aspects of transdermal drug delivery.
    Kligman AM
    Am Heart J; 1984 Jul; 108(1):200-6. PubMed ID: 6731278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of Human Pharmacokinetic Profile After Transdermal Drug Application Using Excised Human Skin.
    Yamamoto S; Karashima M; Arai Y; Tohyama K; Amano N
    J Pharm Sci; 2017 Sep; 106(9):2787-2794. PubMed ID: 28315690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.